REDHILL BIOPHARMA LTD. Proceeds From Issue Of Ordinary Shares
REDHILL BIOPHARMA LTD. (RDHL) reported Proceeds From Issue Of Ordinary Shares of $3.45 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfOrdinaryShares · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. proceeds from issue of ordinary shares for the quarter ending 2022-06-30 was $15.51M, a 5580.59% increase year-over-year.
- REDHILL BIOPHARMA LTD. proceeds from issue of ordinary shares for the quarter ending 2021-06-30 was $273.00K, a 95.71% decline year-over-year.
- REDHILL BIOPHARMA LTD. proceeds from issue of ordinary shares for the quarter ending 2020-06-30 was $6.36M.
| Period end | Proceeds From Issue Of Ordinary Shares | Proceeds From Issue Of Ordinary Shares 3 month | Proceeds From Issue Of Ordinary Shares 6 month | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|---|---|---|
| 2025-06-30 | $3.45M 6-K · filed 2025-09-05 | |||
| 2024-12-31 | $8.26M 20-F · filed 2025-04-10 | |||
| 2024-06-30 | $8.26M 6-K · filed 2025-09-05 | |||
| 2024-04-03 | $1.25M 20-F · filed 2025-04-10 | |||
| 2023-12-31 | $13.96M 20-F · filed 2025-04-10 | |||
| 2023-06-30 | $5.10M 6-K · filed 2024-08-29 | |||
| 2022-12-31 | $23.81M 20-F · filed 2025-04-10 | |||
| 2022-06-30 | $15.51M 6-K · filed 2022-11-07 | $16.22M 6-K · filed 2023-08-17 | ||
| 2021-12-31 | $78.54M 20-F · filed 2024-04-08 | |||
| 2021-06-30 | $273.00K 6-K · filed 2022-11-07 | $58.21M 6-K · filed 2022-11-07 | ||
| 2020-12-31 | $23.87M 20-F · filed 2023-04-28 | |||
| 2020-06-30 | $6.36M 6-K · filed 2021-08-26 | $6.36M 6-K · filed 2021-08-26 | ||
| 2019-12-31 | $36.30M 20-F · filed 2022-03-17 | |||
| 2018-12-31 | $41.90M 20-F · filed 2021-03-18 |